Sorry, this entry is only available in Ukrainian.
Українські фармвиробники виконали окреслені для взаємовизнання GMP-сертифікатів умови, готові до фармбезвізу з ЄС
Вас может заинтересовать:
WEB only
Investment of 350 million EUR in state-of-the-art research infrastructure is Boehringer Ingelheim’s largest single investment in Germany to date Boehringer Ingelheim strengthens innovation power and development of biopharmaceuticals, which account…
WEB only
Pharmaceutical Company ‘Darnytsia’ has registered in Poland a medicinal product used in the complex treatment of acute and chronic heart failure, acute and chronic renal failure, nephrotic syndrome, liver diseases,…
